Search results
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters· 7 hours ago, opens new tab missed Wall Street estimates for quarterly profit on Thursday, hurt by softer sales...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
GuruFocus.com via Yahoo Finance· 13 hours agoResearch and Development: R&D expenses increased by 13% to $1.248 billion, reflecting ongoing...
Regeneron misses earnings, revenue expectations By Investing.com
Investing.com· 14 hours agoRegeneron (NASDAQ:REGN) experienced a slight decline in its stock price, falling 1.82% after...
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
FierceBiotech· 11 hours agoThe approved GLP-1 medicines, Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, are known to cause...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenge
Guru Focus· 13 hours agoRevenue: Reported at $3.15 billion, a decrease of 1% year-over-year, falling short of estimates of $3.22 billion.Net Income: GAAP net income reached $722 milli
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact By Reuters
Investing.com· 14 hours agoApart from an impact of about $40 million cut in inventory, Regeneron said changing market dynamics...
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
Market Watch· 15 hours agoBy Denny Jacob Regeneron Pharmaceuticals posted lower-than-expected revenue in its latest quarter which resulted in part from lower sales of EYLEA in the...
Regeneron’s stock rallies as pipeline prospects outweigh earnings miss
Market Watch· 15 hours agoThe revenue shortfall was partly due to a decline in sales of the company’s blockbuster eye drug...
UPDATE 3-Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 15 hours ago(Adds details on Eylea sales miss in paragraph 2, consensus estimates for Eylea 8mg in paragraph 5) May 2 (Reuters) - U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall ...
Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks· 21 hours agoAlthough the revenue and EPS for Regeneron (REGN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics ...